Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy
Department of Woman, Child and Public Health, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy.
Int J Gynecol Cancer. 2021 Aug;31(8):1154-1158. doi: 10.1136/ijgc-2020-002288. Epub 2021 Apr 21.
During the COVID-19 pandemic, cancer care had to be reorganized; national and international recommendations were published to manage anticancer treatments safely and to reduce the risk of SARS-CoV-2 infection for patients and health workers.
To evaluate whether the adoption of recommendations for the management of patients with gynaecologic cancer receiving treatment during the pandemic resulted in containment of infections and continuing oncologic care.
Based on the published recommendations, and according to the local Health Direction guidelines, we developed and drafted a security protocol to modify access of patients with gynaecologic cancer to the "Fondazione Policlinico Agostino Gemelli-IRCCS, Rome" between February 1 and April 30, 2020 and compared results with the corresponding 3 months of 2019.
Between February and April 2019, we registered 3254 admissions, including 2253 patients receiving intravenous chemotherapies, 298 receiving oral therapies, and 703 having hospital visits. Between February and April 2020, we registered 3213 admissions, including 2221 patients receiving intravenous chemotherapies, 401 receiving oral therapies, and 591 having hospital visits. Oral treatments and general visits were different in the two time periods (p<0.001). Despite the elevated patient flow, only one patient (0.1%) tested positive for COVID-19 and there were no cases among healthcare staff.
Based on the adopted security protocol we provided continuity of care for all patients and limited the spread of the COVID-19 infection.
在 COVID-19 大流行期间，癌症治疗必须重新组织；发布了国家和国际建议，以安全管理抗癌治疗并降低患者和卫生工作者感染 SARS-CoV-2 的风险。
评估在大流行期间管理接受治疗的妇科癌症患者的建议的采用是否导致了感染的控制和肿瘤学护理的持续进行。
根据已发表的建议，并根据当地卫生署的指导方针，我们制定并起草了一份安全协议，以修改妇科癌症患者进入“罗马 Fondazione Policlinico Agostino Gemelli-IRCCS”的通道，时间为 2020 年 2 月 1 日至 4 月 30 日，并将结果与 2019 年同期的结果进行比较。
2019 年 2 月至 4 月期间，我们登记了 3254 例入院，其中 2253 例患者接受静脉化疗，298 例患者接受口服治疗，703 例患者进行了门诊就诊。2020 年 2 月至 4 月期间，我们登记了 3213 例入院，其中 2221 例患者接受静脉化疗，401 例患者接受口服治疗，591 例患者进行了门诊就诊。两个时期的口服治疗和一般就诊不同（p<0.001）。尽管患者流量增加，但只有 1 例患者（0.1%）COVID-19 检测呈阳性，且医护人员中无病例。
根据采用的安全协议，我们为所有患者提供了护理的连续性，并限制了 COVID-19 感染的传播。
